Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02517905 · ClinicalTrials.gov registry record · Phase 3
Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction
A Phase 3 study of Dental Pain, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT02517905: Completed Phase 3 study of Dental Pain, sponsored by Pacira Pharmaceuticals.
NCT02517905 is a Phase 3 study of Dental Pain that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 166 participants, below the 218-participant average among 6 other Dental Pain trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02517905, a Phase 3 study of Dental Pain, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 3, randomized, double-blind, placebo-controlled study in subjects scheduled to undergo elective bilateral third molar extraction under local anesthesia. At least one lower mandibular third molar must involve full or partial bony impaction confirmed by visual or radiographic evidence.
Primary Outcome
AUC of NRS pain intensity scores through 48 hours. Pain intensity scores were measured on a 10-point scale (0=no pain and 10=worst possible pain)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Bupivacaine liposome
Study Locations (1)
Utah
- Jean Brown Research - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-01 |
| Phase | Phase 3 |
What the finished NCT02517905 record still lists
NCT02517905 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 218-participant average among 6 other Dental Pain trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Dental Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02517905 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT02517905 about?
NCT02517905 is a clinical study titled "Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction". This is a Phase 3, randomized, double-blind, placebo-controlled study in subjects scheduled to undergo elective bilateral third molar extraction under local anesthesia. At least one lower mandibular third molar must involve full or partial bony impaction confirmed by visual or radiographic evidence.
What is the current status of trial NCT02517905?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 166 participants. The study started on 2015-08. Estimated completion is 2016-01.
What conditions does trial NCT02517905 study?
This clinical trial studies the following conditions: Dental Pain.
What interventions are being tested in trial NCT02517905?
The interventions under investigation include: Placebo (DRUG), Bupivacaine liposome (DRUG).
Who is sponsoring clinical trial NCT02517905?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02517905 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dental Pain (Following Third Molar Tooth Extraction) Study
COMPLETED · Phase 3
-
Exploration of the Utility of Dental-dedicated MRI for Dentistry
RECRUITING
-
Photobiomodulation and Tooth Analgesia
RECRUITING · NA
-
Dental Block for Pain Relief in ED Dental Pain Patients
RECRUITING
-
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
COMPLETED · Phase 2
-
Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia